Wir verwenden Cookies und Analyse-Tools, um die Nutzerfreundlichkeit der Internet-Seite zu verbessern und für Marketingzwecke. Wenn Sie fortfahren, diese Seite zu verwenden, nehmen wir an, dass Sie damit einverstanden sind. Zur Datenschutzerklärung.
Fentanyl
CHF 146.75
Auf Lager
SKU
6D494LK30U9
1 Verfügbar 
Geliefert zwischen Do., 30.04.2026 und Fr., 01.05.2026
Details
Fentanyl brand names include Actiq, Duragesic, Fentora, Onsolis, Sublimaze and Instanyl is a synthetic primary -opioid agonist commonly used to treat chronic breakthrough pain and is commonly used in pre-procedures. It is approximately 350 times more potent than morphine, with 100 micrograms of fentanyl approximately equivalent to 10 mg of morphine and 75 mg of pethidine (meperidine) in analgesic activity. It has an LD50 of 3.1 milligrams per kilogram in rats, 0.03 milligrams per kilogram in monkeys, and an undetermined LD50 in humans. mFentanyl was first synthesized by Dr. Paul Janssen in 1960 following the medical inception of meperidine several years earlier. Janssen developed Fentanyl by assaying analogues of the structurally-related drug meperidine for its opioid activity. The widespread use of fentanyl triggered the production of fentanyl citrate, which entered the clinical practice as a general anaesthetic under the trade name Sublimaze in the 1960s.
Weitere Informationen
- Allgemeine Informationen
- Sprache Englisch
- Editor Frederic P. Miller, Agnes F. Vandome, John McBrewster
- Titel Fentanyl
- ISBN 978-613-0-29969-9
- Format Fachbuch
- EAN 9786130299699
- Jahr 2010
- Größe H5mm x B220mm x T150mm
- Untertitel Actiq, Duragesic, Mu Opioid receptor, Chronic pain, Paul Janssen, Sufentanil, Alfentanil, Remifentanil, Lofentanil, Transdermal patch, Controlled Substances Act, Anesthesia
- Gewicht 139g
- Genre Medizin
- Anzahl Seiten 92
- Herausgeber Alphascript Publishing
- GTIN 09786130299699
Bewertungen
Schreiben Sie eine Bewertung
